AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Pavonib 40 Injection

Prescription Icon
Prescription Required

Marketer

Acekinetics Healthcare Pvt Ltd

Salt Composition

Pantoprazole (40mg)

Overview Pavonib 40 Injection

Gastric acid secretion is suppressed by the intravenous medication, Acidol 40 Injection. This treatment addresses various gastrointestinal disorders stemming from excess stomach acid, including acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, providing symptomatic relief and facilitating healing. Acidol 40 Injection is also prophylactically used to prevent stress ulcers in critically ill patients and pre-anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), this injectable medication is administered solely by a healthcare professional when oral forms are deemed unsuitable. Dosage is individualized based on your condition and response, with treatment duration determined by your physician. Consistent use, as directed, is crucial, even with rapid symptom resolution. Lifestyle modifications, such as frequent, smaller meals and avoiding caffeine, spicy, and fatty foods, can enhance treatment efficacy. Common, generally mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal discomfort, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects warrant medical consultation. Prolonged use (over one year) may elevate the risk of bone fractures, particularly at higher doses; discuss bone health maintenance, such as calcium and vitamin D supplementation, with your doctor. Prior to treatment, inform your physician about severe liver impairment, HIV medication use, past allergic reactions to similar drugs, or pre-existing osteoporosis. Pregnant or lactating individuals require medical consultation before use. Alcohol consumption should be avoided due to its acid-stimulating effects. Refrain from operating machinery or driving if experiencing dizziness or drowsiness.

Uses of Pavonib 40 Injection

Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.

Major Benefits of Pavonib 40 Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Pavonib 40 Injection:

  • Diarrhea
  • Flatulence
  • Headache
  • Joint pain
  • Nausea
  • Stomach pain
  • Vomiting
  • Dizziness
  • Thrombophlebitis

How to use Pavonib 40 Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Pavonib 40 Injection works:

Acid reflux and indigestion find relief with Pavonib 40 Injection, a proton pump inhibitor that lessens stomach acid production.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Pavonib 40 Injection is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Pavonib 40 Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Administering Pavonib 40 Injection while breastfeeding appears to be unlikely to cause harm. Available human data indicates minimal risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Pavonib 40 Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

Pavonib 40 Injection poses no safety concerns for individuals with renal impairment; no dosage modification is necessary.

LiverLiverCAUTION

Patients with severe hepatic impairment should receive Pavonib 40 Injection with careful monitoring. Dosage modification for Pavonib 40 Injection may be necessary. Physician consultation is advised.

What if you forget to take Pavonib 40 Injection :

Omitting a scheduled dose of Pavonib 40 Injection warrants immediate physician consultation.

Facts to Know About Pavonib 40 Injection

LabelValue
Type of Compound Benzimidazole sulfoxide analog
Potential for Dependence None.
Type of Medication Gastrointestinal system
Mechanism of Action Gastric acid secretion suppressants

FAQs on Pavonib 40 Injection

A 40mg Pavonib injection treats peptic ulcers, reflux esophagitis, and gastroesophageal reflux disease (GERD). This injection counteracts pain reliever-induced acidity. It also manages Zollinger-Ellison syndrome (ZES), a condition marked by excessive stomach acid. The medication achieves this by lessening stomach acid production, thereby alleviating symptoms.
Concurrent use of antacids and Pavonib 40 Injection is permissible, provided there's a two-hour interval between administrations.
Improvement should be noticeable within 2 to 3 days. However, Pavonib 40 Injection may require up to four weeks to achieve full effectiveness; therefore, some symptoms might persist during this period.
Prolonged Pavonib 40 Injection therapy, while infrequent, can sometimes lead to increased body weight. This may be due to improved reflux symptoms resulting in increased food intake. Address any weight concerns with your physician.
Consumption of alcohol is not recommended while using Pavonib 40 Injection. While alcohol doesn't directly interfere with Pavonib 40 Injection's mechanism, it can elevate stomach acid levels, potentially exacerbating existing symptoms.
Administering Pavonib 40 Injection is optimally done one hour prior to food consumption. Dietary restrictions include spicy and high-fat foods during treatment. Consuming caffeinated beverages, including tea, coffee, and cola, should be avoided. Similarly, alcohol should be omitted, as it could exacerbate existing conditions.
Pavonib 40 Injection is typically recommended for brief treatment. Nevertheless, in cases like peptic ulcer disease or Zollinger-Ellison syndrome, prolonged administration may be deemed necessary. Extended use, however, might elevate the likelihood of adverse reactions and requires careful monitoring and discussion with a physician. Always adhere to your doctor's instructions and remain under their medical guidance when using Pavonib 40 Injection.
Concurrent use of analgesics and Pavonib 40 Injection is considered safe. Pavonib 40 Injection offers protection against the gastric distress and ulcers sometimes caused by painkillers. Administer Pavonib 40 Injection one hour prior to meals, while painkillers are generally best consumed with or following a meal to minimize stomach irritation.
A single dose of Pavonib 40 Injection might not provide adequate relief. Symptom improvement is often seen with just a few doses. Treatment with Pavonib 40 Injection is typically short-term, lasting up to two weeks for conditions like heartburn, indigestion, and acid reflux. Longer-term use may be necessary, though, in cases such as peptic ulcer disease and Zollinger-Ellison syndrome (ZES), as determined by a physician. If symptoms persist after two weeks of regular use as directed, medical advice is recommended.
Extended Pavonib 40 Injection use beyond three months can trigger several adverse reactions. Hypomagnesemia, manifesting as fatigue, confusion, dizziness, tremors, or lightheadedness, is a key concern. Muscle spasms and arrhythmias may also occur. Prolonged therapy exceeding one year elevates the risk of bone fractures, gastrointestinal infections, and vitamin B12 deficiency. This deficiency can cause anemia, characterized by increased fatigue, weakness, pallor, palpitations, dyspnea, vertigo, dyspepsia, anorexia, flatulence, and neurological symptoms like paresthesia and gait disturbances.
Pavonib 40 Injection
36
MRP 44
18% off